Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVela Technologies Regulatory News (VELA)

  • There is currently no data for VELA

Total Voting Rights

1 Dec 2020 07:00

RNS Number : 0120H
Vela Technologies PLC
01 December 2020
 

1 December 2020

 

Vela Technologies plc

("Vela" or the "Company")

 

Total Voting Rights

 

 

The Board of Vela (AIM: VELA) announces that the Company's issued share capital as at the date of this announcement comprises 12,074,071,417 ordinary shares of 0.01 pence each ("Ordinary Shares") with one voting right each. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company is 12,074,071,417.

 

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information, please contact:

 

Vela Technologies plc

Brent Fitzpatrick, Non-Executive Chairman

James Normand, Executive Director

 

Tel: +44 (0) 7421 728875

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: +44 (0) 20 3328 5656

Nick Athanas/Asha Chotai

 

 

Peterhouse Capital Limited (Joint Broker)

Tel: +44 (0) 20 7469 0930

Lucy Williams / Duncan Vasey / Eran Zucker 

 

 

 

About Vela Technologies plc

 

Vela Technologies (AIM: VELA) is an investing company focused on early stage and pre-IPO long term disruptive technology investments. Vela's investee companies have either developed ways of utilising technology or are in the process of developing technology with a view to disrupting the businesses or sector in which they operate. More recently, Vela Technologies has broadened its focus to include existing listed companies where valuations may offer additional opportunities.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRBIBDBXSXDGGG
Date   Source Headline
10th Sep 20214:40 pmRNSSecond Price Monitoring Extn
10th Sep 20214:35 pmRNSPrice Monitoring Extension
9th Sep 20212:05 pmRNSSecond Price Monitoring Extn
9th Sep 20212:00 pmRNSPrice Monitoring Extension
9th Sep 20217:33 amRNSUpdate re. St George Street Capital COVID-19 trial
8th Sep 20214:41 pmRNSSecond Price Monitoring Extn
8th Sep 20214:36 pmRNSPrice Monitoring Extension
7th Sep 20217:00 amRNSExercise of warrants and issue of equity
1st Sep 20217:00 amRNSAppointment of director
27th Aug 20214:41 pmRNSExercise of warrants and issue of equity
18th Aug 20217:00 amRNSUpdate re. St George Street Capital COVID-19 Trial
30th Jul 20215:00 pmRNSTotal Voting Rights
27th Jul 20218:32 amRNSCompletion of investment in Northcoders Group plc
23rd Jul 20217:00 amRNSUpdate re proposed board appointment
22nd Jul 20218:35 amRNS£750,000 investment in Northcoders Group plc
19th Jul 20219:12 amRNSExercise of warrants and issue of equity
9th Jul 202110:53 amRNSUpdate re. St George Street Capital COVID-19 Trial
7th Jul 20213:09 pmRNSExercise of warrants and issue of equity
6th Jul 20212:34 pmRNSExercise of warrants and issue of equity
12th Apr 20217:00 amRNSReplacement: Update re. St George Street Capital
9th Apr 20212:43 pmRNSSale of North Peak & update on investment activity
8th Apr 20214:00 pmRNSUpdate re. St George Street Capital COVID-19 trial
8th Apr 20217:00 amRNSHolding(s) in Company
6th Apr 20215:55 pmRNSUpdate re. investment in Cornerstone FS plc
30th Mar 20217:00 amRNSExercise of warrants and issue of equity
25th Mar 20212:15 pmRNS£200,000 investment in MTI Wireless Edge Ltd
11th Mar 20211:11 pmRNSResult of General Meeting and Total Voting Rights
2nd Mar 20211:03 pmRNSFurther investment in Mode Global Holdings plc
25th Feb 20213:03 pmRNS£350,000 pre-IPO investment in Aeristech
25th Feb 202111:46 amRNSExercise of warrants and issue of equity
23rd Feb 20217:00 amRNSProposed Placing to raise £1.5m and Notice of GM
19th Feb 20211:22 pmRNSUpdate re. investment in Kanabo Group plc
18th Feb 20217:00 amRNSExercise of warrants and issue of equity
17th Feb 20212:05 pmRNSSecond Price Monitoring Extn
17th Feb 20212:00 pmRNSPrice Monitoring Extension
16th Feb 20218:33 amRNSCompletion of investment in Kanabo Group plc
2nd Feb 202112:11 pmRNS£150,000 investment in Kanabo Group plc
22nd Jan 20217:00 amRNSDisposal of holding in BlockchainK2 Corp
11th Jan 20217:00 amRNSUpdate re. St George Street Capital COVID-19 trial
8th Jan 202111:05 amRNSSecond Price Monitoring Extn
8th Jan 202111:00 amRNSPrice Monitoring Extension
7th Jan 20214:41 pmRNSSecond Price Monitoring Extn
7th Jan 20214:36 pmRNSPrice Monitoring Extension
30th Dec 202011:05 amRNSSecond Price Monitoring Extn
30th Dec 202011:00 amRNSPrice Monitoring Extension
18th Dec 20207:00 amRNSUpdate re. St George Street Capital COVID-19 trial
4th Dec 202012:52 pmRNS£200,000 investment in Cornerstone FS plc
1st Dec 20207:00 amRNSTotal Voting Rights
20th Nov 202011:00 amRNSPrice Monitoring Extension
10th Nov 20203:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.